1. You Are At:
  2. English News
  3. India
  4. PM Modi interacts with 3 teams working on COVID-19 vaccine, seeks suggestions on regulatory processes

PM Modi interacts with 3 teams working on COVID-19 vaccine, seeks suggestions on regulatory processes

Prime Minister Narendra Modi on Monday had a virtual meetings with 3 teams working on developing and manufacturing vaccine for COVID-19. These teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

India TV News Desk India TV News Desk
New Delhi Updated on: November 30, 2020 14:51 IST
PM Modi interacts with 3 teams working on COVID-19 vaccine, seeks suggestions on regulatory processe
Image Source : ANI

PM Modi interacts with 3 teams working on COVID-19 vaccine, seeks suggestions on regulatory processes

Prime Minister Narendra Modi on Monday had a virtual meetings with 3 teams working on developing and manufacturing vaccine for COVID-19. These teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad, Prime Minister's Office informed.

During the meeting, PM Modi asked the companies to come out with their suggestions and ideas regarding the regulatory processes and related matters. He also suggested that they should take extra efforts to inform the general public in simple language about the vaccine.

The PM also appreciated the efforts being taken by the scientists in these companies to come out with a vaccine solution to tackle COVID-19. The potential of various platforms for vaccine development was also discussed.

Matters relating to logistics, transport, cold chain in respect of delivering the vaccines were also discussed at the meetings.

PMO said that all the vaccine candidates discussed are at different stages of trials and detailed data and results are expected early next year onwards. The Prime Minister advised all the departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts by these companies bear fruit in order to serve the needs of the country and the entire world.

ALSO READ | Serum Institute rejects charges levelled by vaccine trial participant, seeks ₹100 crore damages from volunteer

On Saturday, Prime Minister Modi had visited Serum Institute of India in Pune as part of efforts to get a first-hand perspective of the preparations, challenges, and roadmap in India's endeavor to vaccinate its citizens against COVID-19.

He had also visited Zydus Biotech Park in Ahmedabad and Bharat Biotech facility at Hyderabad on Saturday as part of his three-city visit to personally review the vaccine development and manufacturing process against COVID-19.

India reported 41,810 new COVID-19 infections in the last 24 hours, taking the tally to 93,92,920, according to the data by the Union Ministry of Health and Family Welfare on Sunday.

The country reported more recoveries than new confirmed cases in the last 24 hours. The total active cases reached 4,53,956 while the total recoveries climbed to 88,02,267 with 42,298 new discharges in a single day. With 496 new deaths, the toll mounted to 1,36,696.

ALSO READ | 'Covidshield' vaccine trial participant alleges neuro breakdown, impaired cognitive functions

Latest India News

Write a comment